Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France. - Pilz MJ; Seyringer S; Nerich V; King MT; Norman R; Gamper EM (PharmacoEconomics, 2025)